302 related articles for article (PubMed ID: 8862003)
1. Unanswered questions about multidrug resistance.
Beck WT
Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
[No Abstract] [Full Text] [Related]
2. Transporter molecules in multidrug resistance.
Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
[No Abstract] [Full Text] [Related]
3. Biology of the multidrug resistance-associated protein, MRP.
Loe DW; Deeley RG; Cole SP
Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
[No Abstract] [Full Text] [Related]
4. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
[No Abstract] [Full Text] [Related]
5. Role of gene amplification in drug resistance.
Schoenlein PV
Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
[No Abstract] [Full Text] [Related]
6. In vitro models of multiple drug resistance.
Greenberger LM; Cohen D; Horwitz SB
Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
[No Abstract] [Full Text] [Related]
7. Clinical reversal of multidrug resistance.
Sikic BI; Fisher GA; Lum BL; Brophy NA; Yahanda AM; Adler KM; Halsey J
Cancer Treat Res; 1994; 73():149-65. PubMed ID: 7710904
[No Abstract] [Full Text] [Related]
8. The role of protein kinase C in multidrug resistance.
O'Brian CA; Ward NE; Gravitt KR; Fan D
Cancer Treat Res; 1994; 73():41-55. PubMed ID: 7710909
[No Abstract] [Full Text] [Related]
9. Both P-gp and MRP contribute to drug resistance in AML.
Legrand O; Simonin G; Zittoun R; Marie JP
Leukemia; 1998 Aug; 12(8):1327-8. PubMed ID: 9697893
[No Abstract] [Full Text] [Related]
10. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Germann UA
Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
[No Abstract] [Full Text] [Related]
11. Molecular diagnosis of multidrug resistance.
Herzog CE; Bates SE
Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
[No Abstract] [Full Text] [Related]
12. [Mechanism of resistance to antitumor agents--its involvement in blood-brain barrier].
Tsuruo T
Yakugaku Zasshi; 1995 Jul; 115(7):513-22. PubMed ID: 7562398
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance is more than MDR1 activity.
Preisler HD
Leuk Res; 1995 Jul; 19(7):429-31. PubMed ID: 7637388
[No Abstract] [Full Text] [Related]
14. The role of P-glycoprotein in drug resistance in multiple myeloma.
Abraham J; Salama NN; Azab AK
Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
[TBL] [Abstract][Full Text] [Related]
15. Chemoresistance in gliomas.
Lu C; Shervington A
Mol Cell Biochem; 2008 May; 312(1-2):71-80. PubMed ID: 18259841
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in breast cancer--is the jury in yet?
Kaye SB
J Natl Cancer Inst; 1997 Jul; 89(13):902-3. PubMed ID: 9214663
[No Abstract] [Full Text] [Related]
17. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
Pirity M; Hevér-Szabó A; Venetianer A
Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of multidrug resistance in breast cancer.
Glazer RI; Rohlff C
Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of multidrug resistance gene expression.
Thorgeirsson SS; Gant TW; Silverman JA
Cancer Treat Res; 1994; 73():57-68. PubMed ID: 7710910
[No Abstract] [Full Text] [Related]
20. Oligonucleotide modulation of multidrug resistance.
Bouffard DY; Ohkawa T; Kijima H; Irie A; Suzuki T; Curcio LD; Holm PS; Sassani A; Scanlon KJ
Eur J Cancer; 1996 Jun; 32A(6):1010-8. PubMed ID: 8763342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
